In a filing, Gilead Sciences, Inc revealed its Officer MERDAD V PARSEY acquired Company’s shares for reported $2.53 million on Mar 03 ’25. In the deal valued at $115.70 per share,21,910 shares were bought.
Then, GILEAD SCIENCES, INC. bought 1,363,636 shares, generating $14,999,996 in total proceeds. Upon buying the shares at $11.00, the 10% Owner now owns 31,424,760 shares.
Before that, Dickinson Andrew D sold 2,500 shares. Gilead Sciences, Inc shares valued at $260,225 were divested by the Chief Financial Officer at a price of $104.09 per share. As a result of the transaction, Dickinson Andrew D now holds 169,061 shares, worth roughly $19.85 million.
Oppenheimer reiterated its Gilead Sciences, Inc [GILD] rating to an Outperform in a research note published on March 04, 2025; the price target was $132. A number of analysts have revised their coverage, including Deutsche Bank’s analysts, who increased its forecast for the stock in mid February from “a Hold” to “a Buy”. DZ Bank also remained covering GILD and has increased its forecast on February 13, 2025 with a “Buy” recommendation from previously “Hold” rating. Morgan Stanley revised its rating on January 10, 2025. It rated GILD as “an Overweight” which previously was an “an Equal-weight”.
Price Performance Review of GILD
On Friday, Gilead Sciences, Inc [NASDAQ:GILD] saw its stock jump 1.18% to $117.41. Over the last five days, the stock has gained 2.71%. Gilead Sciences, Inc shares have risen nearly 27.11% since the year began. Nevertheless, the stocks have risen 60.86% over the past one year. While a 52-week high of $117.39 was reached on 03/07/25, a 52-week low of $62.07 was recorded on 01/10/25. SMA at 50 days reached $99.58, while 200 days put it at $84.56.
Levels Of Support And Resistance For GILD Stock
The 24-hour chart illustrates a support level at 115.33, which if violated will result in even more drops to 113.24. On the upside, there is a resistance level at 118.96. A further resistance level may holdings at 120.50. The Relative Strength Index (RSI) on the 14-day chart is 78.43, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 4.02, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 7.00%. Stochastics %K at 89.53% indicates the stock is a selling.
